Whitehawk Therapeutics (WHWK) Research & Development (2018 - 2025)
Historic Research & Development for Whitehawk Therapeutics (WHWK) over the last 7 years, with Q3 2025 value amounting to $14.3 million.
- Whitehawk Therapeutics' Research & Development rose 4349.3% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.3 million, marking a year-over-year increase of 7449.39%. This contributed to the annual value of $51.0 million for FY2024, which is 429.4% up from last year.
- As of Q3 2025, Whitehawk Therapeutics' Research & Development stood at $14.3 million, which was up 4349.3% from $48.8 million recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' Research & Development registered a high of $48.8 million during Q2 2025, and its lowest value of $3.0 million during Q2 2021.
- In the last 5 years, Whitehawk Therapeutics' Research & Development had a median value of $10.0 million in 2024 and averaged $11.8 million.
- Within the past 5 years, the most significant YoY rise in Whitehawk Therapeutics' Research & Development was 27278.7% (2025), while the steepest drop was 3534.91% (2025).
- Over the past 5 years, Whitehawk Therapeutics' Research & Development (Quarter) stood at $7.2 million in 2021, then increased by 29.65% to $9.4 million in 2022, then surged by 36.26% to $12.8 million in 2023, then increased by 12.37% to $14.3 million in 2024, then dropped by 0.01% to $14.3 million in 2025.
- Its last three reported values are $14.3 million in Q3 2025, $48.8 million for Q2 2025, and $8.8 million during Q1 2025.